Unlock instant, AI-driven research and patent intelligence for your innovation.

Lung cancer screening kit

A technology of kits and reagents, applied in the field of lung cancer screening kits, can solve the problems of missed cure opportunities and low survival rates, and achieve good clinical application prospects

Active Publication Date: 2016-09-07
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At the same time, lung cancer is a disease that is good at hiding. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they are diagnosed with lung cancer symptoms. The best time to cure, the five-year survival rate is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lung cancer screening kit
  • Lung cancer screening kit
  • Lung cancer screening kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 Relationship between expression level of p-LCK and lung cancer

[0022] 1. Experimental method

[0023] 1. Clinical data

[0024] 30 cases of paraffin sections of lung cancer patients and 20 cases of remote controls (refers to the paraffin sections of distal normal lung tissue of lung cancer patients, 5 cm away from the cancer tissue) were selected. The basic information is shown in Table 1.

[0025] Table 1 Basic clinical information

[0026]

[0027] * Note: Others include large cell carcinoma, adenosquamous carcinoma, and small cell carcinoma.

[0028] 2. Detection of p-LCK expression level

[0029] Immunohistochemistry (IHC) using P-LCK as an index was performed on the paraffin sections of lung cancer patients and the control paraffin sections of distant tissues.

[0030] p-LCK antibody: purchased from American affinity company, product number AF3100;

[0031] EnVision TM HRP secondary antibody, antibody diluent, DAB chromogenic reagent, antigen...

Embodiment 2

[0060] Example 2 The composition of the kit for detecting the expression level of p-LCK of the present invention and its application method

[0061] 1. The composition of the immunohistochemical detection kit

[0062] Detection kit (50 copies):

[0063] components

volume

p-LCK antibody

30μl

EnVision TM HRP secondary antibody

100μl

Antibody Diluent

10ml

DAB developer

10ml

Antigen Retrieval Solution

500ml

Wash Buffer *

500ml

immunohistochemistry pen

1 stick

[0064] Note: This kit is based on 100 μl of various experimental reagents added to each slice, and the specific dosage can be appropriately increased or decreased according to the size of the tissue; Wash Buffer * Can be reused 2-3 times.

[0065] 2. How to use the kit

[0066] The lung tissue of the sample to be tested was prepared as a paraffin section as a test specimen, and the expression level of p-LCK was detected acco...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a lung cancer screening kit which comprises an optional reagent for detecting an expression level of p-LCK proteins. The invention further discloses application of the reagent for detecting the expression level of the p-LCK proteins in preparation of a lung cancer screening reagent. The kit disclosed by the invention can judge the risk that a person to be tested suffers from the lung cancer by detecting the expression level of the p-LCK proteins, and can be used for auxiliary diagnosis for clinical lung cancer; an effective basis is provided for relevant treatment measurement taking or decision making, and the clinical application prospect is good.

Description

technical field [0001] The invention relates to a lung cancer screening kit. Background technique [0002] Lung cancer is one of the most common malignant tumors in the world. Its morbidity and mortality are increasing year by year. Currently, the incidence rate ranks first in the world, which seriously threatens human health and life. [0003] The etiology of lung cancer is complex, and it is generally believed that the influencing factors include: ① smoking; ② environmental pollution: such as smog, interior decoration; ③ unhealthy lifestyle: such as poor eating habits, high life pressure; Silicosis, chronic bronchitis; ⑤ Intrinsic factors in the human body: such as family inheritance, decreased immune function, endocrine dysfunction, etc. [0004] At the same time, lung cancer is a disease that is good at hiding. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/574G01N33/68
CPCG01N33/57423G01N33/68
Inventor 唐怀蓉黄燕雷亚莉蒋贤雯唐靖汶李为民张立刘丹宋琛
Owner WEST CHINA HOSPITAL SICHUAN UNIV